We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Snx-2112; Purity- Greater Than Or Equal To 98%; Size- 5 Mg
NETA PART: | CAYM-22359-5 |
MFG.PART: | 22359-5 |
UNSPSC: | 12352200 |
Manufacturer: | Cayman |
Product Description
SNX-2112 is a potent inhibitor of heat shock protein 90 (Hsp90) with a Kd value of 30 nM.1 In vitro, SNX-2112 induces down-regulation of the client proteins HER2 and Akt. It inhibits proliferation in a panel of cancer cell lines (IC50s = 10-50 nM). SNX-2112 (150 mg/kg) completely inhibits tumor growth in a BT474 breast cancer mouse xenograft model. SNX-2112 is also the active metabolite of prodrug SNX-5542 and preferentially accumulates in tumor tissue of mice treated with a single oral dose of 75 mg/kg SNX-5542. Formulations containing SNX-2112 are under clinical investigation for treatment of refractory solid tumors.2
WARNING This product is not for human or veterinary use.
Technical Information
- PF-04928473
- DMF: 0.25 mg/ml
- DMSO: 1 mg/ml
- DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml
Shipping & Storage Information
SKU | CAYM-22359-5 |
---|---|
Supplier Part Number | 22359-5 |
UM | UNIT |
UNSPSC | 12352200 |
Manufacturer Name | Cayman |
MSDS URL | https://www.caymanchem.com/msdss/22359m.pdf |
Temperature | -20 |
Refrigerated-Frozen | Refrigerated |
CountryOfOrigin | US |
ProductLine | CAYM |
Qty | 5 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 2 Business Days |
Hazardous | N |
CAS Number | 908112-43-6 |